Tag: mRNA Technology
FDA Approves Moderna’s mFLUSIVA, the First mRNA-Based Seasonal Influenza Vaccine
Moderna, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved mFLUSIVA (mRNA-1010), making it the first mRNA-based vaccine approved for seasonal influenza.
The vaccine...
Immunoscript Acquires Gennova’s mRNA Division in INR 139 Crore Transaction;Agram Legal Partners Advises
Agram Legal Partners has successfully acted as legal counsel for Immunoscript Life Science Private Limited and its promoter, Dr.Sanjay Singh, in connection with the slump sale acquisition of...